Prophylactic antiviral treatment reduces the incidence of liver failure among patients coinfected with Mycobacterium tuberculosis and hepatitis B virus.

CONCLUSIONS: Prophylactic antiviral treatment reduces the incidence of liver failure in patients coinfected with Mycobacterium tuberculosis and hepatitis B virus; therefore, it is recommended that prophylactic antiviral treatment be administered while receiving anti-tuberculosis treatment in patients coinfected with Mycobacterium tuberculosis and hepatitis B virus. PMID: 31315023 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31315023?dopt=Abstract

Source: Virus Research - July 13, 2019 Category: Virology Authors: Lian J, Hu P, Lu Y, Liu Y, Wang X, Zhang Y, Jia H, Yang Y Tags: Virus Res Source Type: research